|
1.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2.
|
Sun XD, Mu R, Zhou YS, et al:
Investigation and analysis on mortality of gastric cancer in China
between 1990–1992. Chin J Oncol. 24:4–8. 2002.(In Chinese).
|
|
3.
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
4.
|
Zhao JD, Sheng GS, Cao CZ, et al: Analysis
on the morbidity feature among Tibet, Hui and Han nationalities
with gastric cancer in Qinghai area. Chin J Intern Med. 48:955–956.
2009.(In Chinese).
|
|
5.
|
Moy KA, Fan Y, Wang R, Gao YT, Yu MC and
Yuan JM: Alcohol and tobacco use in relation to gastric cancer: a
prospective study of men in Shanghai, China. Cancer Epidemiol
Biomarkers Prev. 19:2287–2297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Konturek PC, Konturek SJ and Brzozowski T:
Helicobacter pylori infection in gastric cancerogenesis. J
Physiol Pharmacol. 60:3–21. 2009.
|
|
7.
|
Shanks AM and El-Omar EM: Helicobacter
pylori infection, host genetics and gastric cancer. J Dig Dis.
10:157–164. 2009. View Article : Google Scholar
|
|
8.
|
Houghton J and Wang TC: Helicobacter
pylori and gastric cancer: a new paradigm for
inflammation-associated epithelial cancers. Gastroenterology.
128:1567–1578. 2008. View Article : Google Scholar
|
|
9.
|
Polk DB and Peek RM Jr: Helicobacter
pylori: gastric cancer and beyond. Nat Rev Cancer. 10:403–414.
2010.10
|
|
10.
|
Gonzalez CA, Pera G, Agudo A, Palli D, et
al: Smoking and the risk of gastric cancer in the European
Prospective Investigation Into Cancer and Nutrition (EPIC). Int J
Cancer. 107:629–634. 2003. View Article : Google Scholar
|
|
11.
|
Gonzalez CA, Sala N and Capella G: Genetic
susceptibility and gastric cancer risk. Int J Cancer. 100:249–260.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Burada F, Angelescu C, Mitrut P, et al:
Interleukin-4 receptor -3223T→C polymorphism is associated with
increased gastric adenocarcinoma risk. Can J Gastroenterol.
26:532–536. 2012.
|
|
13.
|
Zhang Y, Wang ZT and Zhong J:
Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase
1 (NQO1) gene 609 C>T polymorphism is associated with increased
gastric cancer risk in Asians. Genet Mol Res. 11:2328–2337.
2012.PubMed/NCBI
|
|
14.
|
Sakamoto H, Yoshimura K, Saeki N, et al:
Genetic variation in PSCA is associated with susceptibility to
diffuse-type gastric cancer. Nat Genet. 40:730–740. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wu C, Wang G, Yang M, et al: Two genetic
variants in prostate stem cell antigen and gastric cancer
susceptibility in a Chinese population. Mol Carcinog. 48:1131–1138.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lochhead P, Frank B, Hold GL, et al:
Genetic variation in the prostate stem cell antigen gene and upper
gastrointestinal cancer in white individuals. Gastroenterology.
140:435–441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Koivurova OP, Karhukorpi JM, Joensuu ET,
et al: IL-1 RN 2/2 genotype and simultaneous carriage of genotypes
IL-1 RN 2/2 and IL-1beta-511 T/T associated with oesophagitis in
Helicobacter pylori-negative patients. Scand J
Gastroenterol. 38:1217–1222. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Tahara E: Genetic pathways of two types of
gastric cancer. IARC Sci Publ. 157:327–349. 2004.PubMed/NCBI
|
|
19.
|
Won HH, Kim JW, Kim MJ, Kim S, Park JH and
Lee KA: Interleukin 10 polymorphisms differentially influence the
risk of gastric cancer in East Asians and Caucasians. Cytokine.
51:73–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Lu W, Pan K, Zhang L, Lin D, Miao X and
You W: Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8,
IL-10 and tumor necrosis factor a and risk of gastric cancer in a
Chinese population. Carcinogenesis. 26:631–636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Reiter RE, Gu Z, Watabe T, et al: Prostate
stem cell antigen: a cellsurface marker overexpressed in
prostatecancer. Proc Natl Acad Sci USA. 95:1735–1740. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Gumley TP, McKenzie IF and Sandrin MS:
Tissue expression, structure and function of the murine Ly-6 family
of molecules. Immunol Cell Biol. 73:277–296. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Gu Z, Thomas G, Yamashiro J, et al:
Prostate stem cellantigen (PSCA) expression increases with high
gleason score, advanced stage and bone metastasis in prostate
cancer. Oncogene. 19:1288–1296. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Argani P, Rosty C, Reiter RE, et al:
Discovery of new markers of cancer through serial analysis of gene
expression: prostate stem cell antigen is overexpressed in
pancreatic adenocarcinoma. Cancer Res. 61:4320–4324.
2001.PubMed/NCBI
|
|
25.
|
de Nooij-van Dalen AG, van Dongen GA,
Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, Snow GB and
Brakenhoff RH: Chracterization of the human LY-6 antigens, the
newly annotated member Ly-6K included, as molecular markers for
head-and-neck squamous cell carcinoma. Int J Cancer. 103:768–774.
2003.PubMed/NCBI
|
|
26.
|
Bahrenberg G, Brauer A, Joos HG and Jakse
G: Reduced expression of PSCA, a membe of the LY-6 family of cell
surface antigens, in bladder, esophagus and stomach tumors. Biochem
Biophys Res Commun. 275:783–788. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Wang S, Tang J, Wang M, Yuan L and Zhang
Z: Genetic variation in PSCA and bladder cancer susceptibility in a
Chinese population. Carcinogenesis. 31:621–624. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Saffran DC, Raitano AB, Hubert RS, Witte
ON, Reiter RE and Jakobovits A: Anti-PSCA mAbs inhibit tumor growth
and metastasis formation and prolong the survival of mice bearing
human prostate cancer xenografts. Proc NatlAcad Sci USA.
98:2658–2663. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Gu Z, Yamashiro J, Kono E and Reiter RE:
Anti-prostate stem cell antigen monoclonal antibody 1G8 induces
cell death in vitro and inhibits tumor growth in vivo via a
Fc-independent mechanism. Cancer Res. 65:9495–9500. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Shi D, Wang S, Gu D, et al: The PSCA
polymorphisms derived from genome-wide association study are
associated with risk of gastric cancer: a meta-analysis. J Cancer
Res Clin Oncol. 138:1339–1345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Qiao L and Feng Y: Genetic variations of
prostate stem cell antigen (PSCA) contribute to the risk of gastric
cancer for Eastern Asians: a meta-analysis based on 16792
individuals. Gene. 493:83–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Zeng Z, Wu X, Chen F, et al: Polymorphisms
in prostate stem cell antigen gene rs2294008 increase gastric
cancer risk in Chinese. Mol Carcinog. 50:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Ou J, Li K, Ren H, Bai H, Zeng D and Zhang
C: Association and haplotype analysis of prostate stem cell antigen
with gastric cancer in Tibetans. DNA Cell Biol. 29:319–323. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Matsuo K, Tajima K, Suzuki T, et al:
Association of prostate stem cell antigen gene polymorphisms with
the risk of stomach cancer in Japanese. Int J Cancer.
125:1961–1964. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Song HR, Kim HN, Piao JM, et al:
Association of a common genetic variant in prostate stem-cell
antigen with gastric cancer susceptibility in a Korean population.
Mol Carcinog. 50:871–875. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Lu Y, Chen J, Ding Y, et al: Genetic
variation of PSCA gene is associated with the risk of both diffuse-
and intestinal-type gastric cancer in a Chinese population. Int J
Cancer. 127:2183–2189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Gao L, Nieters A and Brenner H:
Meta-analysis: tumour invasion-related genetic polymorphisms and
gastric cancer susceptibility. Aliment Pharmacol Ther. 28:565–573.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Wu T and Kayser B: High altitude
adaptation in Tibetans. High Alt Med Bio. 7:193–208. 2006.
View Article : Google Scholar
|
|
39.
|
Scheinfeldt LB and Tishkoff SA: Living the
high life: high-altitude adaptation. Genome Biol. 11:1332010.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Yao YG, Kong QP, Wang CY, Zhu CL and Zhang
YP: Different matrilineal contributions to genetic structure of
ethnic groups in the silk road region in China. Mol Biol Evol.
21:2265–2280. 2004. View Article : Google Scholar : PubMed/NCBI
|
